Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy - Université de Lille Accéder directement au contenu
Article Dans Une Revue Transplantation Année : 2015

Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy

Résumé

The prognosis of myelodysplastic syndromes (MDS) after allogeneic stem cell transplantation is critically determined by cytogenetic abnormalities, as previously defined by International Prognostic Scoring System (IPSS) cytogenetics. It has been shown that a new cytogenetic classification, included in the IPSS-R (cytogenetic-IPSS-R [C-IPSS-R]), can better predict the outcome of untreated MDS patients.

Dates et versions

hal-03771264 , version 1 (07-09-2022)

Identifiants

Citer

Jordan Gauthier, Gandhi Damaj, Carole Langlois, Marie Robin, Mauricette Michallet, et al.. Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy. Transplantation, 2015, Transplantation, 99 (8), pp.1672-1680. ⟨10.1097/TP.0000000000000649⟩. ⟨hal-03771264⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More